A comprehensive overview of the requirements for drug/device and device/drug combination products in the European Union and the U.S.
Key Quality and Regulatory Aspects for the Development of Combination Products
Nov 5th, 2018Nov 6th, 2018
London, --
GB
Phone:+2077494730
Latest in Home
EANM puts focus on theranostics at 2024 annual meeting
October 4, 2024
GPT-4V flops on RSNA ‘Case of the Day’ questions
October 4, 2024
Philips reveals greenhouse gas emissions success
October 4, 2024
Siemens co-launches €27 million stroke care program
October 3, 2024